Skip to Main Content

The other day, we hosted an hourlong webinar on how to analyze clinical trials to best spot red flags before they cause trouble. The response was terrific and we thank you for your interest.

But because we only had a limited time for the webinar, we weren’t able to address all of your questions. We have collected some more and compiled the responses below.


What conditions compel single-arm trials, given it is not the best mode of testing a drug?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.